Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson’s Disease.
Publication date: Feb 18, 2020 This study aims to determine if one of three low ...
Parkinson’s Disease
This magazine is directed toward patients with Parkinson’s Disease, their families, care givers, physicians and researchers. The content is gathered, validated, categorized, and supplied using a novel big data cyberinfrastructure technology that continually learns about Parkinson’s Disease.
You may filter the results to view only the latest news, media (podcasts and videos) or scientific literature using these buttons.
-
-
Speech, Linguistic and Acoustic Markers in Parkinson’s Disease
Publication date: Feb 18, 2020 We aim to identify speech and language markers that provide ... -
Adaptive Auditive Cueing as a Therapy for Freezing of Gait in Parkinson Patients
Publication date: Feb 18, 2020 The first goal of the study is to investigate whether ... -
New evidence of gut-brain connection in Parkinson’s disease
Publication date: Feb 19, 2020 A new paper published in the journal Nature Neuroscience is ... -
Marijuana And Parkinson’s Disease: What New Research Uncovered
Publication date: Feb 19, 2020 New research coming to light about how Parkinson’s disease progresses ... -
Postmenopausal hormone therapy and Alzheimer’s disease, dementia, and Parkinson’s disease: A systematic review and time-response meta-analysis.
Publication date: Feb 19, 2020 Associations between hormone therapy and Alzheimer’s disease, dementia, and Parkinson’s ... -
New Molecule Has the Potential of Stopping or Slowing Parkinson’s
Publication date: Feb 19, 2020 Parkinson’s disease affects the brain’s nerve cells that produce dopamine. ... -
Autophagy in Parkinson’s disease.
Publication date: Feb 13, 2020 Impaired protein homeostasis and accumulation of damaged or abnormally modified ... -
Endocannabinoid receptors in the CNS: potential drug targets for the prevention and treatment of neurologic and psychiatric disorders.
Publication date: Feb 17, 2020 The endocannabinoid system participates in the regulation of CNS homeostasis ... -
Symptomatic Characteristics of Parkinson’s Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.
Publication date: Feb 17, 2020 Objective When patients take neuroleptics, the distinction between Parkinson’s disease ... -
Primary disruption of the default mode network subsystems in drug-naïve Parkinson’s disease with mild cognitive impairments.
Publication date: Feb 17, 2020 Mild cognitive impairment (MCI) in Parkinson’s disease (PD) is related ... -
Chemoenzymatic Semisynthesis of Phosphorylated α-Synuclein Enables Identification of a Bidirectional Effect on Fibril Formation.
Publication date: Feb 17, 2020 Post-translational modifications (PTMs) impact the pathological aggregation of ?-synuclein (?S), ... -
Associations of ATG7 rs1375206 polymorphism and elevated plasma ATG7 levels with late-onset sporadic Parkinson’s disease in a cohort of Han Chinese from southern China.
Publication date: Feb 17, 2020 Background : Autophagy-related gene 7 (ATG7) plays a key role ... -
Cross-sectional and longitudinal associations between probable REM sleep behavior disorder and impulse control disorders in Parkinson’s disease.
Publication date: Feb 17, 2020 To investigate whether probable rapid eye movement (REM) sleep behavior ... -
The Discovery of LRRK2 Mutations as a Cause of Parkinson’s Disease.
Publication date: Feb 17, 2020 Singleton, A.B. and Gasser, T. The Discovery of LRRK2 Mutations ... -
Tears – more to them than meets the eye: why tears are a good source of biomarkers in Parkinson’s disease.
Publication date: Feb 17, 2020 Tears are a known source of biomarkers for both ocular ... -
Reliability and construct validity of a novel motor-cognitive dual-task test: A Stepping Trail Making Test.
Publication date: Feb 16, 2020 This study aimed to examine the reliability and construct validity ... -
Research: Theoretical Study of Monoamine Oxidase B Inhibitors as Drug Candidates for Treatment of Parkinson’s Disease.
Publication date: Feb 16, 2020 Drugs used for Parkinson’s disease (PD) are based only on ... -
Contrast sensitivity impairment in drug-naïve Parkinson’s disease patients associates with early cognitive decline.
Publication date: Feb 15, 2020 To investigate the contrast sensitivity function in drug-na”ive Parkinson’s disease ... -
Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson’s Disease.
Publication date: Feb 16, 2020 Parkinson’s disease is a progressive neurodegenerative disorder of dopaminergic striatal ... -
Changes to Ventilation, Vocalization, and Thermal Nociception in the Pink1-/- Rat Model of Parkinson’s Disease.
Publication date: Feb 13, 2020 Individuals with Parkinson’s disease (PD) experience significant vocal communication deficits. ...